JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Jaguar Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$2.82−0.71 (-20.00%)
Close on Oct 19, 2026
- Market cap
- $2.28M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Sep 17, 2026 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Apr 30, 2026 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Mar 24, 2025 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| May 23, 2024 | 1-for-60 reverse | Earlier per-share figures multiplied by 60 |
| Jan 23, 2023 | 1-for-75 reverse | Earlier per-share figures multiplied by 75 |
| Sep 8, 2021 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |
| Jun 7, 2019 | 1-for-70 reverse | Earlier per-share figures multiplied by 70 |
| Jun 3, 2019 | 1-for-70 reverse | Earlier per-share figures multiplied by 70 |
| Jun 1, 2018 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 18, 2018 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |